Harnessing the Power of Mesenchymal Stem Cells

Mesenchymal Stem Cells offer a promising avenue for disease modelling and therapy development. One area of focus is on neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease. In the case of Alzheimer’s and Parkinson’s diseases, exosomes and the secretome are increasingly used as therapeutic agents2 to modulate degeneration and promote healing. iPSC- derived MSC lines generated from patients provide an opportunity to create personalized consistent in vitro models without the concern of exhausting the cell bank.

One area where MSC-based disease modelling is proving promising is research into treating bone and cartilage diseases. Mucopolysaccharidosis IVA (Morquio syndrome A) is a lysosomal disease that causes skeletal dysplasia. iPSC-derived MSCs were used to develop a chondrocyte-based model to test possible therapies.3 Acquired tracheomalacia (ATM) is characterized by a loss of strength in the tracheal structure, resulting in difficulty breathing and other complications. In a sheep study,4 MSC-derived chondrocytes were used to develop a tissue engineered implant which resulted in improvement in function.

Uses for these adult stem cells extend beyond regeneration. Unlike some immune cells that can trigger inflammation, MSCs act as moderators. They can suppress excessive immune responses and promote tissue repair. This immunomodulatory prowess makes them ideal for studying and developing drugs for immune-related disorders and conditions characterized by inflammation, such as autoimmune diseases5 or graft-versus-host disease (GVHD).6

Furthermore, MSCs boast a low immunogenicity profile, mitigating the risk of immune rejection and facilitating allogeneic7 transplantation without the need for stringent matching criteria. This remarkable feature underscores the potential of MSC-based therapies for off-the-shelf availability, expediting treatment delivery and broadening accessibility to patients in need.

MSCs are active participants in the healing process.8 For example, a number of studies9 have examined the utility of MSCs and exosomes from them as aids in skin wound healing. MSCs secrete a rich cocktail of bioactive molecules, including growth factors, cytokines, and extracellular vesicles. These paracrine factors play a crucial role in tissue repair and regeneration by influencing the behavior of neighboring cells and tissues. Understanding these factors can aid in the development of drugs that mimic or enhance their beneficial effects.

Rapid advancements in biomedical research have emphasized the necessity for innovative drug discovery tools, and MSCs are emerging as a pivotal resource. Their remarkable ability to differentiate into various cell types makes them invaluable in regenerative medicine and drug studies, offering insights into drug effects and aiding in identifying targets. Derived from sources like bone marrow or generated through reprogramming adult cells, MSCs exhibit versatility and promise treating conditions ranging from bone defects to neurodegenerative diseases to tissue repair. Moreover, subcellular fractions of MSCs, such as exosomes and the secretome, are actively investigated for therapeutic applications due to their immunomodulatory properties. Because of their beneficial properties, MSCs are reshaping the landscape of pharmaceutical innovation and therapeutic development.